{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:17:05Z","timestamp":1794215825357,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mesenchymal stromal cells (MSCs) within the protective microenvironment of multiple myeloma (MM) promote tumor growth, confer chemoresistance and support metabolic needs of plasma cells (PCs) even transferring mitochondria. In this scenario, heterocellular communication and dysregulation of critical signaling axes are among the major contributors to progression and treatment failure. Here, we report that myeloma MSCs have decreased reliance on mitochondrial metabolism as compared to healthy MSCs and increased tendency to deliver mitochondria to MM cells, suggesting that this intercellular exchange between PCs and stromal cells can be consider part of MSC pro-tumorigenic phenotype. Interestingly, we also showed that PCs promoted expression of connexin 43 (CX43) in MSCs leading to CXCL12 activation and stimulation of its receptor CXCR4 on MM cells favoring protumor mitochondrial transfer. Consistently, we observed that selective inhibition of CXCR4 by plerixafor resulted in a significant reduction of mitochondria trafficking. Moreover, intracellular expression of CXCR4 in myeloma PCs from BM biopsy specimens demonstrated higher CXCR4 colocalization with CD138+ cells of non-responder patients to bortezomib compared with responder patients, suggesting that CXCR4 mediated chemoresistance in MM. Taken together, our data demonstrated that CXCL12\/CXCR4 axis mediates intercellular coupling thus suggesting that the myeloma niche may be exploited as a target to improve and develop therapeutic approaches.<\/jats:p>","DOI":"10.1038\/s41389-022-00380-z","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T05:03:16Z","timestamp":1642741396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["CXCL12\/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment"],"prefix":"10.1038","volume":"11","author":[{"given":"Cesarina","family":"Giallongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Dulcamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-8556","authenticated-orcid":false,"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Del Fabro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunziatina","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Scandura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Conticello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Li Volti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Amorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelino","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u2019hammed","family":"Aguennouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-4696","authenticated-orcid":false,"given":"Rosalba","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-6319","authenticated-orcid":false,"given":"Giuseppe A.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"380_CR1","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla A, Anderson KC. Multiple myeloma: The (r)evolution of current therapy and a glance into future. Haematologica. 2020;105:2358\u201367.","journal-title":"Haematologica"},{"key":"380_CR2","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.redox.2020.101611","volume":"36","author":"G Camiolo","year":"2020","unstructured":"Camiolo G, Barbato A, Giallongo C, Vicario N, Romano A, Parrinello NL, et al. Iron regulates myeloma cell\/macrophage interaction and drives resistance to bortezomib. Redox Biol. 2020;36:101611.","journal-title":"Redox Biol"},{"key":"380_CR3","doi-asserted-by":"publisher","first-page":"4462.","DOI":"10.3390\/ijms22094462","volume":"22","author":"N Giannakoulas","year":"2021","unstructured":"Giannakoulas N, Ntanasis-Stathopoulos I, Terpos E. The role of marrow microenvironment in the growth and development of malignant plasma cells in multiple myeloma. Int J Mol Sci. 2021;22:4462.","journal-title":"Int J Mol Sci"},{"key":"380_CR4","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-17-2627","volume":"24","author":"C Schinke","year":"2018","unstructured":"Schinke C, Qu P, Mehdi SJ, Hoering A, Epstein J, Johnson SK, et al. The pattern of mesenchymal stem cell expression is an independent marker of outcome in multiple myeloma. Clin Cancer Res. 2018;24:2913\u20139.","journal-title":"Clin Cancer Res"},{"key":"380_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","volume":"377","author":"K De Veirman","year":"2016","unstructured":"De Veirman K, Wang J, Xu S, Leleu X, Himpe E, Maes K, et al. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity. Cancer Lett. 2016;377:17\u201324.","journal-title":"Cancer Lett"},{"key":"380_CR6","doi-asserted-by":"publisher","first-page":"85764","DOI":"10.18632\/oncotarget.7969","volume":"7","author":"C Giallongo","year":"2016","unstructured":"Giallongo C, Tibullo D, Parrinello NL, La Cava P, Di Rosa M, Bramanti V, et al. Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC). Oncotarget. 2016;7:85764\u201375.","journal-title":"Oncotarget"},{"key":"380_CR7","doi-asserted-by":"crossref","unstructured":"Giallongo C, Tibullo D, Camiolo G, Parrinello NL, Romano A, Puglisi F, et al. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death Dis. 2019;10:704.","DOI":"10.1038\/s41419-019-1959-5"},{"key":"380_CR8","doi-asserted-by":"crossref","unstructured":"Lemaitre L, DoSouto Ferreira L, Joubert MV, Avet-Loiseau H, Martinet L, Corre J, et al. Imprinting of mesenchymal stromal cell transcriptome persists even after treatment in patients with multiple myeloma. Int J Mol Sci. 2020;21:3854.","DOI":"10.3390\/ijms21113854"},{"key":"380_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","volume":"22","author":"MME de Jong","year":"2021","unstructured":"de Jong MME, Kellermayer Z, Papazian N, Tahri S, Hofste Op Bruinink D, Hoogenboezem R, et al. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat Immunol. 2021;22:769\u201380.","journal-title":"Nat Immunol"},{"key":"380_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/sctm.18-0070","volume":"8","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yuan X, Munoz N, Logan TM, Ma T. Commitment to aerobic glycolysis sustains immunosuppression of human mesenchymal stem cells. Stem Cells Transl Med. 2019;8:93\u2013106.","journal-title":"Stem Cells Transl Med"},{"key":"380_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","volume":"130","author":"CR Marlein","year":"2017","unstructured":"Marlein CR, Zaitseva L, Piddock RE, Robinson SD, Edwards DR, Shafat MS, et al. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood. 2017;130:1649\u201360.","journal-title":"Blood"},{"key":"380_CR12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","volume":"79","author":"CR Marlein","year":"2019","unstructured":"Marlein CR, Piddock RE, Mistry JJ, Zaitseva L, Hellmich C, Horton RH, et al. CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma. Cancer Res. 2019;79:2285\u201397.","journal-title":"Cancer Res"},{"key":"380_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","volume":"128","author":"R Moschoi","year":"2016","unstructured":"Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. 2016;128:253\u201364.","journal-title":"Blood"},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-018-0554-z","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang J, Liu X, Qiu Y, Shi Y, Cai J, Wang B, et al. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol. 2018;11:11.","journal-title":"J Hematol Oncol"},{"key":"380_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BCJ20200710","volume":"478","author":"G Pinto","year":"2021","unstructured":"Pinto G, Saenz-de-Santa-Maria I, Chastagner P, Perthame E, Delmas C, Toulas C, et al. Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids. Biochem J. 2021;478:21\u201339.","journal-title":"Biochem J"},{"key":"380_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/cdd.2017.51","volume":"24","author":"M Mahrouf-Yorgov","year":"2017","unstructured":"Mahrouf-Yorgov M, Augeul L, Da Silva CC, Jourdan M, Rigolet M, Manin S, et al. Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties. Cell Death Differ. 2017;24:1224\u201338.","journal-title":"Cell Death Differ"},{"key":"380_CR17","first-page":"994","volume":"33","author":"T Ahmad","year":"2014","unstructured":"Ahmad T, Mukherjee S, Pattnaik B, Kumar M, Singh S, Kumar M, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 2014;33:994\u20131010.","journal-title":"EMBO J"},{"key":"380_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759\u201365.","journal-title":"Nat Med"},{"key":"380_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10428194.2014.913289","volume":"56","author":"X Zhang","year":"2015","unstructured":"Zhang X, Sun Y, Wang Z, Huang Z, Li B, Fu J. Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells. Leuk Lymphoma. 2015;56:211\u20138.","journal-title":"Leuk Lymphoma"},{"key":"380_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ab.2003.07.013","volume":"322","author":"G Lazzarino","year":"2003","unstructured":"Lazzarino G, Amorini AM, Fazzina G, Vagnozzi R, Signoretti S, Donzelli S, et al. Single-sample preparation for simultaneous cellular redox and energy state determination. Anal Biochem. 2003;322:51\u201359.","journal-title":"Anal Biochem"},{"key":"380_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.bbadis.2014.04.005","volume":"1842","author":"AM Amorini","year":"2014","unstructured":"Amorini AM, Nociti V, Petzold A, Gasperini C, Quartuccio E, Lazzarino G, et al. Serum lactate as a novel potential biomarker in multiple sclerosis. Biochim Biophys Acta. 2014;1842:1137\u201343.","journal-title":"Biochim Biophys Acta"},{"key":"380_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/mmr.2014.2678","volume":"11","author":"Y Xu","year":"2015","unstructured":"Xu Y, Lu S. Transforming growth factor-beta1-induced epithelial to mesenchymal transition increases mitochondrial content in the A549 non-small cell lung cancer cell line. Mol Med Rep. 2015;11:417\u201321.","journal-title":"Mol Med Rep"},{"key":"380_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cpmo.21","volume":"7","author":"PM Quiros","year":"2017","unstructured":"Quiros PM, Goyal A, Jha P, Auwerx J. Analysis of mtDNA\/nDNA ratio in mice. Curr Protoc Mouse Biol. 2017;7:47\u201354.","journal-title":"Curr Protoc Mouse Biol"},{"key":"380_CR24","doi-asserted-by":"crossref","unstructured":"Vicario N, Bernstock JD, Spitale FM, Giallongo C, Giunta MAS, Li Volti G, et al. Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation. Int J Mol Sci. 2019;20:1991.","DOI":"10.3390\/ijms20081991"},{"key":"380_CR25","doi-asserted-by":"crossref","unstructured":"Camiolo G, Tibullo D, Giallongo C, Romano A, Parrinello NL, Musumeci G, et al. alpha-Lipoic acid reduces iron-induced toxicity and oxidative stress in a model of iron overload. Int J Mol Sci. 2019;20:609.","DOI":"10.3390\/ijms20030609"},{"key":"380_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.stem.2017.11.002","volume":"21","author":"MJ de Almeida","year":"2017","unstructured":"de Almeida MJ, Luchsinger LL, Corrigan DJ, Williams LJ, Snoeck HW. Dye-independent methods reveal elevated mitochondrial mass in hematopoietic stem cells. Cell Stem Cell. 2017;21:725\u20139 e724.","journal-title":"Cell Stem Cell"},{"key":"380_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/tra.12786","volume":"22","author":"RP Norris","year":"2021","unstructured":"Norris RP. Transfer of mitochondria and endosomes between cells by gap junction internalization. Traffic. 2021;22:174\u20139.","journal-title":"Traffic"},{"key":"380_CR28","doi-asserted-by":"publisher","unstructured":"Ren D, Zheng P, Zou S, Gong Y, Wang Y, Duan J, et al. GJA1-20K Enhances mitochondria transfer from astrocytes to neurons via Cx43-TnTs after traumatic brain injury. Cell Mol Neurobiol. 2021. https:\/\/doi.org\/10.1007\/s10571-021-01070-x.","DOI":"10.1007\/s10571-021-01070-x"},{"key":"380_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ni.2017","volume":"12","author":"A Schajnovitz","year":"2011","unstructured":"Schajnovitz A, Itkin T, D\u2019Uva G, Kalinkovich A, Golan K, Ludin A, et al. CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol. 2011;12:391\u20138.","journal-title":"Nat Immunol"},{"key":"380_CR30","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1111\/jcmm.13177","volume":"21","author":"N Vicario","year":"2017","unstructured":"Vicario N, Calabrese G, Zappala A, Parenti C, Forte S, Graziano ACE, et al. Inhibition of Cx43 mediates protective effects on hypoxic\/reoxygenated human neuroblastoma cells. J Cell Mol Med. 2017;21:2563\u201372.","journal-title":"J Cell Mol Med"},{"key":"380_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/onc.2015.139","volume":"35","author":"F Guo","year":"2016","unstructured":"Guo F, Wang Y, Liu J, Mok SC, Xue F, Zhang W. CXCL12\/CXCR4: A symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene. 2016;35:816\u201326.","journal-title":"Oncogene"},{"key":"380_CR32","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","volume":"113","author":"AK Azab","year":"2009","unstructured":"Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, Leleu X, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113:4341\u201351.","journal-title":"Blood"},{"key":"380_CR33","doi-asserted-by":"publisher","first-page":"604143","DOI":"10.3389\/fonc.2020.604143","volume":"10","author":"A Barbato","year":"2020","unstructured":"Barbato A, Scandura G, Puglisi F, Cambria D, La Spina E, Palumbo GA, et al. Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: An overview. Front Oncol. 2020;10:604143.","journal-title":"Front Oncol"},{"key":"380_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","volume":"27","author":"YC Cohen","year":"2021","unstructured":"Cohen YC, Zada M, Wang SY, Bornstein C, David E, Moshe A, et al. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat Med. 2021;27:491\u2013503.","journal-title":"Nat Med"},{"key":"380_CR35","doi-asserted-by":"crossref","unstructured":"Giallongo C, Tibullo D, Puglisi F, Barbato A, Vicario N, Cambria D, et al. Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells. Cancers. 2020;12:1999.","DOI":"10.3390\/cancers12081999"},{"key":"380_CR36","doi-asserted-by":"crossref","unstructured":"Tibullo D, Giallongo C, Romano A, Vicario N, Barbato A, Puglisi F, et al. Mitochondrial functions, energy metabolism, and protein glycosylation are interconnected processes mediating resistance to bortezomib in multiple myeloma cells. Biomolecules. 2020;10:696.","DOI":"10.3390\/biom10050696"},{"key":"380_CR37","doi-asserted-by":"publisher","first-page":"545126","DOI":"10.3389\/fcell.2020.545126","volume":"8","author":"AH Nwabo Kamdje","year":"2020","unstructured":"Nwabo Kamdje AH, Seke Etet PF, Simo Tagne R, Vecchio L, Lukong KE, Krampera M. Tumor microenvironment uses a reversible reprogramming of mesenchymal stromal cells to mediate pro-tumorigenic effects. Front Cell Dev Biol. 2020;8:545126.","journal-title":"Front Cell Dev Biol"},{"key":"380_CR38","doi-asserted-by":"crossref","unstructured":"Tibullo D, Longo A, Vicario N, Romano A, Barbato A, Di Rosa M, et al. Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells. Cancers. 2020;12:323.","DOI":"10.3390\/cancers12020323"},{"key":"380_CR39","doi-asserted-by":"publisher","first-page":"118088","DOI":"10.1016\/j.lfs.2020.118088","volume":"257","author":"J Huang","year":"2020","unstructured":"Huang J, Huang LQ, He HS, Yan J, Huang C, Wang R, et al. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2\/STAT3 pathway. Life Sci. 2020;257:118088.","journal-title":"Life Sci"},{"key":"380_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-021-01031-3","volume":"14","author":"Z Ren","year":"2021","unstructured":"Ren Z, Lantermans H, Kuil A, Kraan W, Arenzana-Seisdedos F, Kersten MJ, et al. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma. J Hematol Oncol. 2021;14:11.","journal-title":"J Hematol Oncol"},{"key":"380_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.13594","volume":"205","author":"Z Liu","year":"2021","unstructured":"Liu Z, Mi F, Han M, Tian M, Deng L, Meng N, et al. Bone marrow-derived mesenchymal stem cells inhibit CD8(+) T cell immune responses via PD-1\/PD-L1 pathway in multiple myeloma. Clin Exp Immunol. 2021;205:53\u201362.","journal-title":"Clin Exp Immunol"},{"key":"380_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.canlet.2015.11.028","volume":"380","author":"JM Bouyssou","year":"2016","unstructured":"Bouyssou JM, Ghobrial IM, Roccaro AM. Targeting SDF-1 in multiple myeloma tumor microenvironment. Cancer Lett. 2016;380:315\u20138.","journal-title":"Cancer Lett"},{"key":"380_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/path.1876","volume":"208","author":"M Parmo-Cabanas","year":"2006","unstructured":"Parmo-Cabanas M, Molina-Ortiz I, Matias-Roman S, Garcia-Bernal D, Carvajal-Vergara X, Valle I, et al. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes. J Pathol. 2006;208:108\u201318.","journal-title":"J Pathol"},{"key":"380_CR44","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","volume":"109","author":"Y Alsayed","year":"2007","unstructured":"Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, et al. Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood. 2007;109:2708\u201317.","journal-title":"Blood"},{"key":"380_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/leu.2013.254","volume":"28","author":"MA Frassanito","year":"2014","unstructured":"Frassanito MA, Rao L, Moschetta M, Ria R, Di Marzo L, De, Luisi A, et al. Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. Leukemia. 2014;28:904\u201316.","journal-title":"Leukemia"},{"key":"380_CR46","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3389\/fphys.2017.01060","volume":"8","author":"N Vicario","year":"2017","unstructured":"Vicario N, Zappala A, Calabrese G, Gulino R, Parenti C, Gulisano M, et al. Connexins in the central nervous system: Physiological traits and neuroprotective targets. Front Physiol. 2017;8:1060.","journal-title":"Front Physiol"},{"key":"380_CR47","doi-asserted-by":"crossref","unstructured":"Peruzzotti-Jametti L, Bernstock JD, Willis CM, Manferrari G, Rogall R, Fernandez-Vizarra E, et al. Neural stem cells traffic functional mitochondria via extracellular vesicles. PLoS Biol. 2021;19:e3001166.","DOI":"10.1371\/journal.pbio.3001166"},{"key":"380_CR48","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1182\/blood.2020005399","volume":"136","author":"K Golan","year":"2020","unstructured":"Golan K, Singh AK, Kollet O, Bertagna M, Althoff MJ, Khatib-Massalha E, et al. Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma. Blood. 2020;136:2607\u201319.","journal-title":"Blood"},{"key":"380_CR49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.stemcr.2018.09.012","volume":"11","author":"Y Yao","year":"2018","unstructured":"Yao Y, Fan XL, Jiang D, Zhang Y, Li X, Xu ZB, et al. Connexin 43-mediated mitochondrial transfer of iPSC-MSCs alleviates asthma inflammation. Stem Cell Rep. 2018;11:1120\u201335.","journal-title":"Stem Cell Rep"},{"key":"380_CR50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.CCR-19-0647","volume":"26","author":"IM Ghobrial","year":"2020","unstructured":"Ghobrial IM, Liu CJ, Redd RA, Perez RP, Baz R, Zavidij O, et al. A phase Ib\/II trial of the first-in-class anti-CXCR4 antibody Ulocuplumab in combination with lenalidomide or bortezomib plus dexamethasone in relapsed multiple myeloma. Clin Cancer Res. 2020;26:344\u201353.","journal-title":"Clin Cancer Res"},{"key":"380_CR51","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ajh.25627","volume":"94","author":"IM Ghobrial","year":"2019","unstructured":"Ghobrial IM, Liu CJ, Zavidij O, Azab AK, Baz R, Laubach JP, et al. Phase I\/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed\/refractory multiple myeloma. Am J Hematol. 2019;94:1244\u201353.","journal-title":"Am J Hematol"},{"key":"380_CR52","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.3324\/haematol.2018.207704","volume":"104","author":"L Besse","year":"2019","unstructured":"Besse L, Besse A, Mendez-Lopez M, Vasickova K, Sedlackova M, Vanhara P, et al. A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding, and sphingomyelin synthesis. Haematologica. 2019;104:e415\u2013e419.","journal-title":"Haematologica"},{"key":"380_CR53","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1158\/0008-5472.CAN-17-0115","volume":"77","author":"K Vandyke","year":"2017","unstructured":"Vandyke K, Zeissig MN, Hewett DR, Martin SK, Mrozik KM, Cheong CM, et al. HIF-2alpha promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12\/CXCR4 and CCR1. Cancer Res. 2017;77:5452\u201363.","journal-title":"Cancer Res"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00380-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:13:01Z","timestamp":1669212781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00380-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1038\/s41389-022-00380-z","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}